Qingdao Vland Biotech INC. (SHA:603739)

China flag China · Delayed Price · Currency is CNY
15.42
-0.16 (-1.03%)
At close: Mar 9, 2026
14.99%
Market Cap 3.90B
Revenue (ttm) 1.39B
Net Income (ttm) 83.57M
Shares Out 253.03M
EPS (ttm) 0.33
PE Ratio 46.52
Forward PE n/a
Dividend 0.10 (0.64%)
Ex-Dividend Date May 30, 2025
Volume 4,386,500
Average Volume 5,274,318
Open 15.50
Previous Close 15.58
Day's Range 15.32 - 15.55
52-Week Range 12.23 - 18.41
Beta 0.52
RSI 49.44
Earnings Date Apr 25, 2026

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antivir... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 1,535
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603739
Full Company Profile

Financial Performance

In 2024, SHA:603739's revenue was 1.32 billion, an increase of 10.16% compared to the previous year's 1.20 billion. Earnings were 62.64 million, a decrease of -22.39%.

Financial Statements

News

There is no news available yet.